ZA200504572B - Fremented milk product comprising tripeptide VPP and/or IPP - Google Patents

Fremented milk product comprising tripeptide VPP and/or IPP Download PDF

Info

Publication number: ZA200504572B
Authority: ZA; South Africa
Prior art keywords: fermentation; fermented milk; mmol; milk product; ipp
Prior art date: 2003-01-06

Application number

ZA200504572A

Other languages

English (en)

Inventor

Rene B Draaisma

Mettina M G Koning

Adrianus M Lederboer

Johannes Schalk

Original Assignee

Unilever Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-01-06

Filing date

2005-06-03

Publication date

2006-08-30

2005-06-03 Application filed by Unilever Plc filed Critical Unilever Plc

2006-08-30 Publication of ZA200504572B publication Critical patent/ZA200504572B/en

Links

235000013336 milk Nutrition 0.000 title description 22
239000008267 milk Substances 0.000 title description 22
210000004080 milk Anatomy 0.000 title description 22
NUHSROFQTUXZQQ-UHFFFAOYSA-N isopentenyl diphosphate Chemical compound CC(=C)CCO[P@](O)(=O)OP(O)(O)=O NUHSROFQTUXZQQ-UHFFFAOYSA-N 0.000 title 1
238000000855 fermentation Methods 0.000 claims description 75
230000004151 fermentation Effects 0.000 claims description 75
235000014048 cultured milk product Nutrition 0.000 claims description 37
235000015140 cultured milk Nutrition 0.000 claims description 23
239000011575 calcium Substances 0.000 claims description 21
238000000034 method Methods 0.000 claims description 19
239000011777 magnesium Substances 0.000 claims description 16
150000002500 ions Chemical class 0.000 claims description 12
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
240000002605 Lactobacillus helveticus Species 0.000 claims description 9
235000013967 Lactobacillus helveticus Nutrition 0.000 claims description 9
229940054346 lactobacillus helveticus Drugs 0.000 claims description 9
239000007787 solid Substances 0.000 claims description 8
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 7
238000002360 preparation method Methods 0.000 claims description 7
239000001301 oxygen Substances 0.000 claims description 6
229910052760 oxygen Inorganic materials 0.000 claims description 6
150000003839 salts Chemical class 0.000 claims description 5
238000004519 manufacturing process Methods 0.000 claims description 4
239000000758 substrate Substances 0.000 claims description 3
241000961787 Josa Species 0.000 claims description 2
MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 2
239000001527 calcium lactate Substances 0.000 claims description 2
235000011086 calcium lactate Nutrition 0.000 claims description 2
229960002401 calcium lactate Drugs 0.000 claims description 2
159000000007 calcium salts Chemical class 0.000 claims description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical group [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims description 2
159000000003 magnesium salts Chemical class 0.000 claims description 2
XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims description 2
JREYOWJEWZVAOR-UHFFFAOYSA-N triazanium;[3-methylbut-3-enoxy(oxido)phosphoryl] phosphate Chemical compound [NH4+].[NH4+].[NH4+].CC(=C)CCOP([O-])(=O)OP([O-])([O-])=O JREYOWJEWZVAOR-UHFFFAOYSA-N 0.000 claims 3
FQYQMFCIJNWDQZ-CYDGBPFRSA-N Ile-Pro-Pro Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 FQYQMFCIJNWDQZ-CYDGBPFRSA-N 0.000 description 45
108010031424 isoleucyl-prolyl-proline Proteins 0.000 description 45
DOFAQXCYFQKSHT-SRVKXCTJSA-N Val-Pro-Pro Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DOFAQXCYFQKSHT-SRVKXCTJSA-N 0.000 description 39
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 30
235000013305 food Nutrition 0.000 description 21
102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 20
108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 20
KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 15
229960000448 lactic acid Drugs 0.000 description 15
239000004310 lactic acid Substances 0.000 description 14
235000014655 lactic acid Nutrition 0.000 description 14
108090000765 processed proteins & peptides Proteins 0.000 description 12
239000000047 product Substances 0.000 description 12
239000007858 starting material Substances 0.000 description 12
230000000694 effects Effects 0.000 description 11
230000005764 inhibitory process Effects 0.000 description 11
102000004196 processed proteins & peptides Human genes 0.000 description 11
241000894006 Bacteria Species 0.000 description 9
235000020183 skimmed milk Nutrition 0.000 description 9
AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 8
239000000920 calcium hydroxide Substances 0.000 description 8
235000011116 calcium hydroxide Nutrition 0.000 description 8
229940095643 calcium hydroxide Drugs 0.000 description 8
229910001861 calcium hydroxide Inorganic materials 0.000 description 8
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 8
230000000052 comparative effect Effects 0.000 description 8
235000013365 dairy product Nutrition 0.000 description 8
239000000203 mixture Substances 0.000 description 8
102000011632 Caseins Human genes 0.000 description 7
108010076119 Caseins Proteins 0.000 description 7
229910052791 calcium Inorganic materials 0.000 description 7
235000021240 caseins Nutrition 0.000 description 7
239000000839 emulsion Substances 0.000 description 7
230000002797 proteolythic effect Effects 0.000 description 7
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
240000004808 Saccharomyces cerevisiae Species 0.000 description 6
235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 6
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
239000004615 ingredient Substances 0.000 description 6
230000020477 pH reduction Effects 0.000 description 6
235000013618 yogurt Nutrition 0.000 description 6
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
102000035195 Peptidases Human genes 0.000 description 5
108091005804 Peptidases Proteins 0.000 description 5
230000015572 biosynthetic process Effects 0.000 description 5
229960005069 calcium Drugs 0.000 description 5
235000009508 confectionery Nutrition 0.000 description 5
239000000796 flavoring agent Substances 0.000 description 5
235000019634 flavors Nutrition 0.000 description 5
239000003921 oil Substances 0.000 description 5
235000019198 oils Nutrition 0.000 description 5
229910052700 potassium Inorganic materials 0.000 description 5
235000011118 potassium hydroxide Nutrition 0.000 description 5
229940093932 potassium hydroxide Drugs 0.000 description 5
235000019833 protease Nutrition 0.000 description 5
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
150000001413 amino acids Chemical class 0.000 description 4
230000036772 blood pressure Effects 0.000 description 4
239000005018 casein Substances 0.000 description 4
235000015243 ice cream Nutrition 0.000 description 4
229910052751 metal Inorganic materials 0.000 description 4
239000002184 metal Substances 0.000 description 4
230000017854 proteolysis Effects 0.000 description 4
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
208000024172 Cardiovascular disease Diseases 0.000 description 3
241000282414 Homo sapiens Species 0.000 description 3
206010020772 Hypertension Diseases 0.000 description 3
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
239000005862 Whey Substances 0.000 description 3
102000007544 Whey Proteins Human genes 0.000 description 3
108010046377 Whey Proteins Proteins 0.000 description 3
239000002253 acid Substances 0.000 description 3
235000001014 amino acid Nutrition 0.000 description 3
239000012131 assay buffer Substances 0.000 description 3
229940021722 caseins Drugs 0.000 description 3
238000011081 inoculation Methods 0.000 description 3
229910052500 inorganic mineral Inorganic materials 0.000 description 3
150000003893 lactate salts Chemical class 0.000 description 3
235000010755 mineral Nutrition 0.000 description 3
239000011707 mineral Substances 0.000 description 3
239000011591 potassium Substances 0.000 description 3
239000000843 powder Substances 0.000 description 3
235000020122 reconstituted milk Nutrition 0.000 description 3
239000000523 sample Substances 0.000 description 3
239000003381 stabilizer Substances 0.000 description 3
235000000346 sugar Nutrition 0.000 description 3
229940088594 vitamin Drugs 0.000 description 3
235000013343 vitamin Nutrition 0.000 description 3
239000011782 vitamin Substances 0.000 description 3
229930003231 vitamin Natural products 0.000 description 3
102400000345 Angiotensin-2 Human genes 0.000 description 2
101800000733 Angiotensin-2 Proteins 0.000 description 2
XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 description 2
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
241000186660 Lactobacillus Species 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
229930006000 Sucrose Natural products 0.000 description 2
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
239000000654 additive Substances 0.000 description 2
125000003277 amino group Chemical group 0.000 description 2
229950006323 angiotensin ii Drugs 0.000 description 2
238000003556 assay Methods 0.000 description 2
XOEMATDHVZOBSG-UHFFFAOYSA-N azafenidin Chemical group C1=C(OCC#C)C(Cl)=CC(Cl)=C1N1C(=O)N2CCCCC2=N1 XOEMATDHVZOBSG-UHFFFAOYSA-N 0.000 description 2
230000004531 blood pressure lowering effect Effects 0.000 description 2
230000015556 catabolic process Effects 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
239000006071 cream Substances 0.000 description 2
229910001873 dinitrogen Inorganic materials 0.000 description 2
238000010494 dissociation reaction Methods 0.000 description 2
230000005593 dissociations Effects 0.000 description 2
235000013399 edible fruits Nutrition 0.000 description 2
238000000705 flame atomic absorption spectrometry Methods 0.000 description 2
239000007850 fluorescent dye Substances 0.000 description 2
235000012041 food component Nutrition 0.000 description 2
239000005417 food ingredient Substances 0.000 description 2
239000007789 gas Substances 0.000 description 2
239000003112 inhibitor Substances 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
230000003834 intracellular effect Effects 0.000 description 2
-1 lactate ion Chemical class 0.000 description 2
229910052749 magnesium Inorganic materials 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
238000002156 mixing Methods 0.000 description 2
UPSFMJHZUCSEHU-JYGUBCOQSA-N n-[(2s,3r,4r,5s,6r)-2-[(2r,3s,4r,5r,6s)-5-acetamido-4-hydroxy-2-(hydroxymethyl)-6-(4-methyl-2-oxochromen-7-yl)oxyoxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide Chemical compound CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](NC(C)=O)[C@H](OC=2C=C3OC(=O)C=C(C)C3=CC=2)O[C@@H]1CO UPSFMJHZUCSEHU-JYGUBCOQSA-N 0.000 description 2
235000018102 proteins Nutrition 0.000 description 2
102000004169 proteins and genes Human genes 0.000 description 2
108090000623 proteins and genes Proteins 0.000 description 2
238000011002 quantification Methods 0.000 description 2
239000011734 sodium Substances 0.000 description 2
229910052708 sodium Inorganic materials 0.000 description 2
239000005720 sucrose Substances 0.000 description 2
239000006228 supernatant Substances 0.000 description 2
239000002562 thickening agent Substances 0.000 description 2
108010015385 valyl-prolyl-proline Proteins 0.000 description 2
HJYMFKIKNPNGPA-YYLRFZLMSA-N (2s)-5-amino-2-[[(2s)-1-[(2s)-2-[[(2s)-1-[(2s)-2-[[(2s)-2-[[(2s)-2,6-diaminohexanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoic acid Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N1[C@H](C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 HJYMFKIKNPNGPA-YYLRFZLMSA-N 0.000 description 1
239000005541 ACE inhibitor Substances 0.000 description 1
240000006766 Cornus mas Species 0.000 description 1
235000003363 Cornus mas Nutrition 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
241000282412 Homo Species 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
108010038807 Oligopeptides Proteins 0.000 description 1
102000015636 Oligopeptides Human genes 0.000 description 1
HJSCRFZVGXAGNG-SRVKXCTJSA-N Pro-Gln-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1 HJSCRFZVGXAGNG-SRVKXCTJSA-N 0.000 description 1
108010009736 Protein Hydrolysates Proteins 0.000 description 1
241000235070 Saccharomyces Species 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
PMHLLBKTDHQMCY-ULQDDVLXSA-N Tyr-Lys-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O PMHLLBKTDHQMCY-ULQDDVLXSA-N 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 description 1
125000000539 amino acid group Chemical group 0.000 description 1
229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
235000020244 animal milk Nutrition 0.000 description 1
239000002220 antihypertensive agent Substances 0.000 description 1
229910052786 argon Inorganic materials 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
235000015173 baked goods and baking mixes Nutrition 0.000 description 1
230000000975 bioactive effect Effects 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000000872 buffer Substances 0.000 description 1
239000000337 buffer salt Substances 0.000 description 1
238000011088 calibration curve Methods 0.000 description 1
235000020248 camel milk Nutrition 0.000 description 1
FAKRSMQSSFJEIM-RQJHMYQMSA-N captopril Chemical compound SC[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O FAKRSMQSSFJEIM-RQJHMYQMSA-N 0.000 description 1
229960000830 captopril Drugs 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
235000013351 cheese Nutrition 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
239000013065 commercial product Substances 0.000 description 1
238000001816 cooling Methods 0.000 description 1
235000020247 cow milk Nutrition 0.000 description 1
235000011950 custard Nutrition 0.000 description 1
235000021245 dietary protein Nutrition 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
239000003480 eluent Substances 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
235000013861 fat-free Nutrition 0.000 description 1
235000003599 food sweetener Nutrition 0.000 description 1
235000021433 fructose syrup Nutrition 0.000 description 1
239000008369 fruit flavor Substances 0.000 description 1
235000013572 fruit purees Nutrition 0.000 description 1
235000013376 functional food Nutrition 0.000 description 1
239000003349 gelling agent Substances 0.000 description 1
235000020251 goat milk Nutrition 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
235000020252 horse milk Nutrition 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
150000004679 hydroxides Chemical class 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
238000000099 in vitro assay Methods 0.000 description 1
230000001433 inducive effect Effects 0.000 description 1
239000011261 inert gas Substances 0.000 description 1
239000002054 inoculum Substances 0.000 description 1
229940039696 lactobacillus Drugs 0.000 description 1
230000007774 longterm Effects 0.000 description 1
OVGXLJDWSLQDRT-UHFFFAOYSA-L magnesium lactate Chemical compound [Mg+2].CC(O)C([O-])=O.CC(O)C([O-])=O OVGXLJDWSLQDRT-UHFFFAOYSA-L 0.000 description 1
239000000626 magnesium lactate Substances 0.000 description 1
235000015229 magnesium lactate Nutrition 0.000 description 1
229960004658 magnesium lactate Drugs 0.000 description 1
239000000463 material Substances 0.000 description 1
229910021645 metal ion Inorganic materials 0.000 description 1
244000005700 microbiome Species 0.000 description 1
235000020124 milk-based beverage Nutrition 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
235000019629 palatability Nutrition 0.000 description 1
238000001637 plasma atomic emission spectroscopy Methods 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
239000003531 protein hydrolysate Substances 0.000 description 1
230000036454 renin-angiotensin system Effects 0.000 description 1
239000012723 sample buffer Substances 0.000 description 1
235000015067 sauces Nutrition 0.000 description 1
238000012216 screening Methods 0.000 description 1
235000011888 snacks Nutrition 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000000243 solution Substances 0.000 description 1
235000021262 sour milk Nutrition 0.000 description 1
239000000725 suspension Substances 0.000 description 1
239000003765 sweetening agent Substances 0.000 description 1
239000008399 tap water Substances 0.000 description 1
235000020679 tap water Nutrition 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
230000003639 vasoconstrictive effect Effects 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1322—Inorganic compounds; Minerals, including organic salts thereof, oligo-elements; Amino-acids, peptides, protein-hydrolysates or derivatives; Nucleic acids or derivatives; Yeast extract or autolysate; Vitamins; Antibiotics; Bacteriocins
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/147—Helveticus

Landscapes

Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Microbiology (AREA)
Engineering & Computer Science (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Health & Medical Sciences (AREA)
Nutrition Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Dairy Products (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

ZA200504572A 2003-01-06 2005-06-03 Fremented milk product comprising tripeptide VPP and/or IPP ZA200504572B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP03075017		2003-01-06

Publications (1)

Publication Number	Publication Date
ZA200504572B true ZA200504572B (en)	2006-08-30

Family

ID=32695593

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200504572A ZA200504572B (en)	2003-01-06	2005-06-03	Fremented milk product comprising tripeptide VPP and/or IPP

Country Status (14)

Country	Link
US (1)	US20060246178A1 (zh)
EP (1)	EP1581062A1 (zh)
JP (1)	JP2006512912A (zh)
CN (1)	CN1735347A (zh)
AR (1)	AR042703A1 (zh)
AU (1)	AU2003296605B2 (zh)
BR (1)	BR0316782A (zh)
CA (1)	CA2509627A1 (zh)
CL (1)	CL2004000014A1 (zh)
EA (1)	EA200501093A1 (zh)
MX (1)	MXPA05007267A (zh)
PL (1)	PL378232A1 (zh)
WO (1)	WO2004060073A1 (zh)
ZA (1)	ZA200504572B (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2006525003A (ja)	2003-05-05	2006-11-09	ユニリーバー・ナームローゼ・ベンノートシヤープ	Ｉｐｐおよび／またはｖｐｐを含む加水分解カゼイン製品
NZ551700A (en)	2004-05-03	2009-04-30	Hansens Lab	Enzymatic process for obtaining increased yield of lactobionic acid
BRPI0611469A2 (pt) *	2005-04-28	2010-09-08	Unilever Nv	usos do tripeptìdeo itp e produto alimentìcio
EP1874129A1 (en) *	2005-04-28	2008-01-09	Unilever PLC	Peptides having an ace inhibiting effect
DE602006020977D1 (de) *	2006-02-20	2011-05-12	Gervais Danone Sa	Neue Lactobacillus Helveticus Stämme
EP1820851B9 (fr)	2006-02-20	2012-06-27	Compagnie Gervais Danone	Souches de Lactobacillus helveticus ne fermentant pas le lactose
ES2320482T3 (es)	2006-02-20	2009-05-22	Compagnie Gervais Danone	Nuevas cepas de lactobacillus helveticus.
ES2323087T3 (es) *	2006-02-20	2009-07-06	Compagnie Gervais Danone	Nuevas cepas de lactobacillus helveticus.
FI122531B (fi) *	2009-09-30	2012-03-15	Valio Oy	Juusto ja menetelmä sen valmistamiseksi
MX346592B (es) *	2010-12-20	2017-03-24	Nestec Sa	Modulacion de sabor por bio-procesamiento usando cepas bacterianas formadoras de sabor.
SG10201509907UA (en)	2010-12-20	2016-01-28	Nestec Sa	Flavour modulation by bio-processing using cream-flavour forming bacteria strains
CN102948476A (zh) *	2012-11-19	2013-03-06	陕西科技大学	一种基于瑞士乳杆菌发酵的含ace抑制肽的羊乳饮料的制备方法
CN102960444A (zh) *	2012-11-19	2013-03-13	陕西科技大学	一种基于瑞士乳杆菌发酵的含ace抑制肽的羊奶的制备方法
CN103204909B (zh) *	2013-04-17	2014-09-03	苏州凯祥生物科技有限公司	一种抗高血压活性肽vppipp

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL8703019A (nl) *	1987-12-14	1989-07-03	Nl Zuivelonderzoek Inst	Werkwijze voor de bereiding van gefermenteerde melkprodukten.
US5130148A (en) *	1991-05-06	1992-07-14	Brown C Gordon	Method of cheese manufacture
JP2782142B2 (ja) *	1992-07-23	1998-07-30	カルピス株式会社	アンジオテンシン変換酵素阻害剤及びその製造法
JP2824821B2 (ja) *	1993-11-04	1998-11-18	カルピス株式会社	乳酸菌及び発酵乳製品
JP3782837B2 (ja)	1995-04-10	2006-06-07	カルピス株式会社	血圧降下剤及びその製造法
JP3028411B2 (ja)	1997-09-26	2000-04-04	カルピス株式会社	トリペプチド高生産性ラクトバチルス・ヘルベチカス乳酸菌
US6475759B1 (en) *	1997-10-14	2002-11-05	Cargill, Inc.	Low PH lactic acid fermentation
DK1142481T4 (da) *	1999-01-11	2009-12-21	Calpis Co Ltd	Fremgangsmåde til fremstilling af fermenteret mælk indeholdende et peptid, der inhiberer et angiotensinomdannende enzym og fremgangsmåde til fremstilling af mælkeserum
FI113741B (fi) *	1999-11-01	2004-06-15	Valio Oy	Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
US7323199B2 (en) *	2000-06-14	2008-01-29	Vrije Universiteit Brussel	Method for the preparation of yoghurt and other fermented milk products
AU2002302385B2 (en) *	2001-03-09	2005-10-06	Unilever Plc	Fermented milk product
NZ511202A (en) *	2001-04-19	2002-11-26	New Zealand Dairy Board	Savoury-flavoured food product produced in a short time by fermentation of a protein-based medium by at least two different strains of food-grade bacteria
CA2488264A1 (en) *	2002-06-03	2003-12-11	Vrije Universiteit Brussel	Streptococcus thermophilus strain producing exopolysaccharide

2003
- 2003-12-03 EA EA200501093A patent/EA200501093A1/ru unknown
- 2003-12-03 US US10/541,477 patent/US20060246178A1/en not_active Abandoned
- 2003-12-03 CA CA002509627A patent/CA2509627A1/en not_active Abandoned
- 2003-12-03 AU AU2003296605A patent/AU2003296605B2/en not_active Ceased
- 2003-12-03 JP JP2004564195A patent/JP2006512912A/ja not_active Withdrawn
- 2003-12-03 BR BR0316782-8A patent/BR0316782A/pt not_active Application Discontinuation
- 2003-12-03 MX MXPA05007267A patent/MXPA05007267A/es not_active Application Discontinuation
- 2003-12-03 WO PCT/EP2003/013644 patent/WO2004060073A1/en active IP Right Grant
- 2003-12-03 CN CN200380108334.0A patent/CN1735347A/zh active Pending
- 2003-12-03 EP EP03814460A patent/EP1581062A1/en not_active Withdrawn
- 2003-12-03 PL PL378232A patent/PL378232A1/pl not_active Application Discontinuation
2004
- 2004-01-05 AR ARP040100009A patent/AR042703A1/es not_active Application Discontinuation
- 2004-01-05 CL CL200400014A patent/CL2004000014A1/es unknown
2005
- 2005-06-03 ZA ZA200504572A patent/ZA200504572B/en unknown

Also Published As

Publication number	Publication date
US20060246178A1 (en)	2006-11-02
AU2003296605B2 (en)	2007-06-28
WO2004060073A1 (en)	2004-07-22
EA200501093A1 (ru)	2005-12-29
EP1581062A1 (en)	2005-10-05
PL378232A1 (pl)	2006-03-20
AR042703A1 (es)	2005-06-29
CN1735347A (zh)	2006-02-15
JP2006512912A (ja)	2006-04-20
MXPA05007267A (es)	2005-09-08
CA2509627A1 (en)	2004-07-22
CL2004000014A1 (es)	2005-03-28
BR0316782A (pt)	2005-11-01
AU2003296605A1 (en)	2004-07-29

Publication	Publication Date	Title
AU2004237455B2 (en)	2007-08-02	Hydrolysed casein product comprising tripeptides IPP and/ or VPP
ZA200504572B (en)	2006-08-30	Fremented milk product comprising tripeptide VPP and/or IPP
EP1226267B1 (en)	2004-05-12	Process for producing a product containing antihypertensive tripeptides
AU2002302385B2 (en)	2005-10-06	Fermented milk product
AU2002302385A1 (en)	2003-03-20	Fermented milk product
TWI395552B (zh)	2013-05-11	產製醱酵乳之方法及醱酵乳食品和飲料
EP1469738B1 (en)	2008-01-30	Cheese flavour ingredient and method of its production
AU2004237456B8 (en)	2007-10-04	Peptides having an ace inhibiting effect
JP2007513900A (ja)	2007-05-31	Ａｃｅ阻害効果を有するペプチド